Amitriptylinoxide

Amitriptylinoxide.png

Amitriptylinoxide is a tricyclic antidepressant (TCA) that is used primarily in the treatment of major depressive disorder. It is a metabolite of amitriptyline, which is also a tricyclic antidepressant. Amitriptylinoxide is known for its efficacy in alleviating symptoms of depression and its pharmacological profile is similar to that of amitriptyline.

Pharmacology

Amitriptylinoxide works by inhibiting the reuptake of serotonin and norepinephrine, two neurotransmitters that are believed to play a key role in mood regulation. By preventing the reabsorption of these neurotransmitters, amitriptylinoxide increases their levels in the synaptic cleft, thereby enhancing neurotransmission and improving mood.

Indications

Amitriptylinoxide is primarily indicated for the treatment of major depressive disorder. It may also be used off-label for other conditions such as anxiety disorders, chronic pain, and migraine prophylaxis.

Side Effects

Common side effects of amitriptylinoxide include dry mouth, constipation, urinary retention, blurred vision, and drowsiness. More serious side effects can include cardiac arrhythmias, orthostatic hypotension, and seizures. Due to its side effect profile, it is generally recommended to monitor patients closely, especially during the initial stages of treatment.

Contraindications

Amitriptylinoxide is contraindicated in patients with a history of myocardial infarction, arrhythmias, or severe liver disease. It should also be used with caution in patients with bipolar disorder due to the risk of inducing mania.

Interactions

Amitriptylinoxide can interact with a variety of other medications, including monoamine oxidase inhibitors (MAOIs), other antidepressants, and certain antihypertensive drugs. These interactions can lead to serious side effects such as serotonin syndrome or hypertensive crises.

Dosage

The dosage of amitriptylinoxide varies depending on the condition being treated and the patient's response to the medication. It is typically started at a low dose and gradually increased to minimize side effects.

History

Amitriptylinoxide was developed as a metabolite of amitriptyline to provide a potentially more effective and better-tolerated treatment option for depression. It has been used clinically for several decades and remains a valuable option in the pharmacotherapy of depression.

See Also

• Amitriptyline
• Tricyclic antidepressant
• Major depressive disorder
• Serotonin
• Norepinephrine

External Links

Amitriptylinoxide.png

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian